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Background: Familial hypercholesterolemia (FH) is associated with increased cardiovascular risk. We evaluated the effect of FH on intima-media 
thickness of the femoral artery (fIMT), which is a measure of subclinical atherosclerosis.
methods: We meta-analyzed case-control studies, reporting fIMT in untreated FH patients and in normocholesterolemic controls of similar age. For 
each eligible study we calculated the mean difference (MD) with 95% confidence intervals (CIs) for fIMT (FH minus controls). A random-effects model 
was used to calculate pooled MDs. To estimate the contribution of continuous study moderators (age, cholesterol levels) on our estimates, we ran 
meta-regression analysis with restricted maximum likelihood.
results: A total of 5 cohorts from 4 studies were eligible for our analysis. FH patients had higher fIMT compared with controls [pooled MD 0.35 
mm, 95% confidence interval 0.18 to 0.51 mm, P<0.001 (figure A)]. There was no correlation of each study’s MD of IMT with age (P=0.83). In 
contrast, the difference of total cholesterol between FH patients and controls had a significant association with the MDs of femoral IMT (P=0.001, 
figure B).
conclusions: FH is associated with a significant increase of femoral IMT, an index of subclinical atherosclerosis, compared to normolipidemic 
controls of similar age. The severity of FH expressed with the untreated cholesterol level is a determinant of the femoral artery wall thickness.
 
